Valuation: Healius Limited

Market Cap 330M 237M 203M 190M 174M 326M 22.66B 2.24B 875M 11.38B 889M 870M 37.65B P/E 2026
-0.68x
P/E 2027 * -31.6x
Enterprise Value 1.24B 887M 760M 711M 651M 1.22B 84.91B 8.4B 3.28B 42.66B 3.33B 3.26B 141B EV / Sales 2026
0.88x
EV / Sales 2027 * 0.89x
Free-Float
77.51%
Yield 2026 *
-
Yield 2027 * -
1 day-2.15%
1 week+13.75%
Current month+21.33%
1 month+28.17%
3 months+26.39%
6 months-34.06%
Current year-49.72%
1 week 0.39
Extreme 0.39
0.51
1 month 0.34
Extreme 0.34
0.51
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
2.92
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
8/18/26 Expiration

Chief Executive Officer

-305,462 0.0421%
11/19/25 Buy

Chief Executive Officer

54,431 0.0075%
11/10/25 Free

Director

45,955 0.0063%
Change 5-day change 1-year change 3-year change Capi.($)
-2.15%+13.75%-45.18%-83.15% 237M
+2.21%+7.13%+100.50%+517.73% 47.86B
+1.06%+5.72%+20.91%+56.60% 27.28B
-1.40%-5.77%-14.31%-34.35% 7.47B
-0.30%+0.62%+9.59%+147.09% 6.05B
+0.25%-1.15%+12.25%+68.30% 3.31B
+5.47%+11.51%-32.33%+1,938.99% 2.6B
+2.72%+6.52%+157.08%+20.60% 2.18B
+1.92%+4.29%-0.70%-49.36% 2.16B
+2.36%+2.47%+31.46%+20.67% 1.97B
Average +1.21%+4.78%+23.93%+260.31% 10.11B
Weighted average by Cap. +1.50%+5.12%+56.19%+318.25%

Financials

2026 2027 *
Net sales 1.38B 988M 846M 792M 725M 1.36B 94.53B 9.36B 3.65B 47.49B 3.71B 3.63B 157B 1.41B 1.01B 868M 813M 744M 1.4B 97B 9.6B 3.74B 48.73B 3.81B 3.72B 161B
Net income -27.45M -19.67M -16.85M -15.77M -14.43M -27.09M -1.88B -186M -72.65M -946M -73.87M -72.27M -3.13B -10.83M -7.76M -6.65M -6.22M -5.69M -10.69M -743M -73.5M -28.66M -373M -29.15M -28.51M -1.23B
Net Debt 908M 651M 557M 521M 477M 896M 62.25B 6.16B 2.4B 31.27B 2.44B 2.39B 103B 934M 669M 573M 536M 491M 921M 64.03B 6.34B 2.47B 32.16B 2.51B 2.46B 106B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
6,000
Date Price Change Volume
26-08-21 A$0.4550 -2.15% 3,913,224
26-08-20 A$0.4650 +10.71% 11,276,191
26-08-19 A$0.4200 -5.62% 10,465,821
26-08-18 A$0.4450 -2.20% 7,481,919
26-08-17 A$0.4550 +13.75% 6,772,205
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.4550AUD
Average target price
0.5474AUD
Spread / Average Target
+20.30%

Quarterly revenue - Rate of surprise